Bicycle Therapeutics (BCYC) Earnings Date & Reports

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BCYC is expected to report earnings to fall 33.75% to -57 cents per share on August 06

Bicycle Therapeutics BCYC Stock Earnings Reports

Q2'26

Est.

$-0.58

Q1'26

Missed

by $0.20

Q4'25

Beat

by $0.65

Q3'25

Beat

by $0.23

Q2'25

Missed

by $0.20

The last earnings report on April 30 showed earnings per share of -87 cents, missing the estimate of -67 cents. With 651.38K shares outstanding, the current market capitalization sits at 285.60M.

View a ticker or compare two or three

Compare

Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)

Annualized Return+19%

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

BCYC

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement